KRTL Holding Group, Inc. manufactures and distributes water. The company is headquartered in Lakewood, Colorado. The company went IPO on 2001-06-21. The firm operates through its subsidiaries, including KRTL Biotech, Inc., KRTL International Corp and Neurogen Brain Balancing, LLC (Neurogen). KRTL Biotech, Inc. is a pharmaceutical company focused on the commercialization of APIs and licensing agreements within the pharmaceutical and nutraceutical sectors. KRTL Biotech, Inc. focuses on biotechnology, particularly in securing and developing global partnerships for the sourcing and distribution of critical APIs and wellness-focused compounds. KRTL International Corp focuses on bridging global markets through international consulting, trade and distribution of advanced bio and agri-technologies and services. Neurogen is a neurotechnology company focused on advanced brain balancing therapies and personalized cognitive optimization systems.
Creative Medical Technology Holdings Inc 주요 수익원은 Regenerative Therapies이며, 최신 수익 발표에서 수익은 6,000입니다. 지역별로는 United States이 Creative Medical Technology Holdings Inc의 주요 시장이며, 수익은 6,000입니다.
KRTL Holding Group Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Creative Medical Technology Holdings Inc의 순손실은 $0입니다.
KRTL Holding Group Inc에 부채가 있나요?
no, Creative Medical Technology Holdings Inc의 부채는 0입니다.
KRTL Holding Group Inc의 발행 주식은 몇 주인가요?
Creative Medical Technology Holdings Inc의 총 발행 주식은 0주입니다.